1. Inhibition of human adenovirus replication by TRIM35-mediated degradation of E1A.
- Author
-
Nan Sun, Jikai Zhang, Chen Zhang, Tan Xie, Zeyu Zhang, Xueyan Wang, Wanjing Li, Yi Zhang, Zhaokai Chen, Junnian Zheng, Lin Fang, and Gang Wang
- Subjects
- *
ADENOVIRUSES , *GLOBAL burden of disease , *PROTEIN expression , *TUMOR treatment , *UBIQUITINATION - Abstract
Human adenovirus (HAdV) is ubiquitous in the human population, constituting a significant burden of global respiratory diseases. Children and individuals with low immunity are at risk of developing severe infections without approved antiviral treatment for HAdV. Our study demonstrated that TRIM35 inhibited HAdV-C5 early gene transcription, early protein expression, genome replication, and infectious virus progeny production. Furthermore, TRIM35 was found to inhibit HAdV replication by attenuating E1A expression. Mechanistically, TRIM35 interacts with and degrades E1A by promoting its K48-linked ubiquitination. Additionally, K253 and K285 are the key sites necessary for TRIM35 degradation. Moreover, an oncolytic adenovirus carrying shTRIM35 was constructed and observed to exhibit improved oncolysis in vivo, providing new ideas for clinical tumor treatment. Our results expand the broad antiviral activity of TRIM35 and mechanically support its application as a HAdV replication inhibitor. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF